The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...
GlobalData on MSN
Labcorp announces colorectal cancer test availability in US
ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results